SEC Tracker
Get the app

Gilead Sciences GILD

Gilead Sciences: signs a material agreement, takes on a new financial obligation and discloses other events

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Signs a material agreement (1.01)
  • Takes on a new financial obligation (2.03)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Gilead Sciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Bristol Myers Squibb BMY public float $94.2B, Jun 30, 2025
  2. Vertex Pharmaceuticals VRTX public float $113.4B, Jun 30, 2025
  3. Pfizer PFE public float $138.0B, Jun 29, 2025
  4. Amgen AMGN public float $150.1B, Jun 30, 2025
  5. Zoetis ZTS public float $69.2B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.